Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€51.44
21.06.21
-
21.06.22
1.09%
21.06.21

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€26.59
20.06.21
-
20.06.22
9.06%
27.06.21

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€47.92
19.06.21
€58.00
19.06.22
-20.72%
27.12.21

Could be worthwhile Investment >10% per year
buy
CytRx Corp.

Start price
Target price
Perf. (%)
€0.056
18.06.21
-
18.06.22
-
18.06.21

buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.52
18.06.21
-
18.06.22
-28.88%
26.07.21

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€53.25
17.06.21
-
09.03.22
-
17.06.21

Could be very worthwhile Investment >20% year
buy
co.don AG

Start price
Target price
Perf. (%)
€1.41
17.06.21
-
17.06.23
-13.17%
17.06.23

Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€10.10
17.06.21
€30.00
17.06.24
-71.39%
02.06.24

buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
17.06.21
-
17.06.25
0.47%
05.07.21

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€20.60
17.06.21
€17.00
17.06.22
38.84%
26.11.21

Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€73.80
17.06.21
€50.00
17.06.22
-66.50%
17.08.21

Could be worthwhile Investment >10% per year
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.34
16.06.21
€60.00
16.06.22
7.13%
28.06.21

buy
Invitae Corp

Start price
Target price
Perf. (%)
€25.02
16.06.21
€40.00
16.06.22
14.15%
28.06.21

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€138.00
16.06.21
€200.00
16.06.22
6.20%
28.06.21

Could be worthwhile Investment >10% per year
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€46.95
16.06.21
€75.00
16.06.22
2.24%
28.06.21

Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€77.60
15.06.21
-
15.06.24
19.07%
11.03.24

Could be worthwhile Investment >10% per year
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€64.56
15.06.21
-
15.06.22
2.17%
21.06.21

Novavax Inc.

Start price
Target price
Perf. (%)
€159.34
15.06.21
-
15.06.22
3.41%
09.07.21

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€54.08
15.06.21
-
15.06.22
-28.72%
24.07.21

buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€16.41
14.06.21
-
14.06.22
-69.20%
18.12.21

Novan Inc

Start price
Target price
Perf. (%)
€15.74
14.06.21
-
14.06.22
-40.72%
17.06.21

Risky Investment
buy
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€13.20
14.06.21
€24.00
14.06.22
0.00%
26.06.21

Could be worthwhile Investment >10% per year
Good culture
Little innovation